{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:14:54Z","timestamp":1791087294172,"version":"4.1.0"},"reference-count":35,"publisher":"American Diabetes Association","issue":"9","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,9,1]]},"abstract":"<jats:p>Diabetic retinopathy is the leading cause of new blindness in adults in developed countries. Leptin, an adipocyte-derived hormone, stimulates endothelial proliferation and angiogenesis. This study was designed to elucidate the pathophysiologic role of leptin in the progression of retinal neovascularization. Using the retinopathy of prematurity model, a mouse model of ischemia-induced retinal neovascularization, we have demonstrated more pronounced retinal neovascularization in 17-day-old transgenic mice overexpressing leptin than in age-matched wild-type littermates. Ischemia-induced retinal neovascularization was markedly suppressed in 17-day-old leptin-deficient ob\/ob mice. Western blot analysis revealed that a biologically active leptin receptor isoform is expressed in mouse retinal endothelial cells. Leptin receptor expression was also detected in primary cultures of porcine retinal endothelial cells, where it upregulated vascular endothelial growth factor (VEGF) mRNA expression. This effect was thought to be mediated at least partly through the activation of signal transducers and activators of transcription (STAT)3, because adenoviral transfection of the dominant-negative form of STAT3 abolished the leptin-induced upregulation of VEGF mRNA expression in retinal endothelial cells. This study provides evidence that leptin stimulates the ischemia-induced retinal neovasucularization possibly through the upregulation of endothelial VEGF, thereby suggesting that leptin antagonism may offer a novel therapeutic strategy to prevent or treat diabetic retinopathy.<\/jats:p>","DOI":"10.2337\/diabetes.53.9.2443","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"2443-2448","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":119,"title":["Leptin Stimulates Ischemia-Induced Retinal Neovascularization"],"prefix":"10.2337","volume":"53","author":[{"given":"Eri","family":"Suganami","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan"},{"name":"Department of Molecular Medicine and Metabolism, Medical Research Institute, Tokyo Medical and Dental University, Chiyoda-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Takagi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Suzuma","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Suzuma","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyasu","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonari","family":"Ojima","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Suganami","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Metabolism, Medical Research Institute, Tokyo Medical and Dental University, Chiyoda-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Fujio","sequence":"additional","affiliation":[{"name":"Department of Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuwa","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Metabolism, Medical Research Institute, Tokyo Medical and Dental University, Chiyoda-ku, Tokyo, Japan"},{"name":"Center of Excellence Program for Frontier Research on Molecular Destruction and Reconstitution of Tooth and Bone, Tokyo Medical and Dental University, Chiyoda-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagahisa","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031208594742100_R1","unstructured":"Smith LE, Wesolowski E, McLellan A, Kostyk SK, D\u2019Amato R, Sullivan R, D\u2019Amore PA: Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci\u200835:101\u2013111,1994"},{"key":"2022031208594742100_R2","doi-asserted-by":"crossref","unstructured":"Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ\u2008321:405\u2013412,2000","DOI":"10.1136\/bmj.321.7258.405"},{"key":"2022031208594742100_R3","doi-asserted-by":"crossref","unstructured":"Engerman RL: Pathogenesis of diabetic retinopathy. Diabetes\u200838:1203\u20131206,1989","DOI":"10.2337\/diabetes.38.10.1203"},{"key":"2022031208594742100_R4","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med\u2008329:977\u2013986,1993","DOI":"10.1056\/NEJM199309303291401"},{"key":"2022031208594742100_R5","doi-asserted-by":"crossref","unstructured":"Matsuzawa Y, Funahashi T, Nakamura T: Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci\u2008892:146\u2013154,1999","DOI":"10.1111\/j.1749-6632.1999.tb07793.x"},{"key":"2022031208594742100_R6","doi-asserted-by":"crossref","unstructured":"Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature\u2008395:763\u2013770,1998","DOI":"10.1038\/27376"},{"key":"2022031208594742100_R7","doi-asserted-by":"crossref","unstructured":"Nakata M, Yada T, Soejima N, Maruyama I: Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes\u200848:426\u2013429,1999","DOI":"10.2337\/diabetes.48.2.426"},{"key":"2022031208594742100_R8","doi-asserted-by":"crossref","unstructured":"Mantzoros CS: The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med\u2008130:671\u2013680,1999","DOI":"10.7326\/0003-4819-130-8-199904200-00014"},{"key":"2022031208594742100_R9","doi-asserted-by":"crossref","unstructured":"Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, Flores-Riveros JR: Biological action of leptin as an angiogenic factor. Science\u2008281:1683\u20131686,1998","DOI":"10.1126\/science.281.5383.1683"},{"key":"2022031208594742100_R10","doi-asserted-by":"crossref","unstructured":"Bouloumie A, Drexler HC, Lafontan M, Busse R: Leptin, the product of Ob gene, promotes angiogenesis. Circ Res\u200883:1059\u20131066,1998","DOI":"10.1161\/01.RES.83.10.1059"},{"key":"2022031208594742100_R11","doi-asserted-by":"crossref","unstructured":"Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med\u2008334:292\u2013295,1996","DOI":"10.1056\/NEJM199602013340503"},{"key":"2022031208594742100_R12","doi-asserted-by":"crossref","unstructured":"Ogawa Y, Masuzaki H, Hosoda K, Aizawa-Abe M, Suga J, Suda M, Ebihara K, Iwai H, Matsuoka N, Satoh N, Odaka H, Kasuga H, Fujisawa Y, Inoue G, Nishimura H, Yoshimasa Y, Nakao K: Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes\u200848:1822\u20131829,1999","DOI":"10.2337\/diabetes.48.9.1822"},{"key":"2022031208594742100_R13","doi-asserted-by":"crossref","unstructured":"Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Nakao K: Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest\u2008105:1243\u20131252,2000","DOI":"10.1172\/JCI8341"},{"key":"2022031208594742100_R14","doi-asserted-by":"crossref","unstructured":"Uckaya G, Ozata M, Bayraktar Z, Erten V, Bingol N, Ozdemir IC: Is leptin associated with diabetic retinopathy?Diabetes Care\u200823:371\u2013376,2000","DOI":"10.2337\/diacare.23.3.371"},{"key":"2022031208594742100_R15","unstructured":"Gariano RF, Nath AK, D\u2019Amico DJ, Lee T, Sierra-Honigmann MR: Elevation of vitreous leptin in diabetic retinopathy and retinal detachment. Invest Ophthalmol Vis Sci\u200841:3576\u20133581,2000"},{"key":"2022031208594742100_R16","doi-asserted-by":"crossref","unstructured":"Suzuma K, Takahara N, Suzuma I, Isshiki K, Ueki K, Leitges M, Aiello LP, King GL: Characterization of protein kinase C \u03b2 isoform\u2019s action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization. Proc Natl Acad Sci U S A\u200899:721\u2013726,2002","DOI":"10.1073\/pnas.022644499"},{"key":"2022031208594742100_R17","unstructured":"Takagi H, King GL, Robinson GS, Ferrara N, Aiello LP: Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Ophthalmol Vis Sci\u200837:2165\u20132176,1996"},{"key":"2022031208594742100_R18","doi-asserted-by":"crossref","unstructured":"King GL, Goodman AD, Buzney S, Moses A, Kahn CR: Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest\u200875:1028\u20131036,1985","DOI":"10.1172\/JCI111764"},{"key":"2022031208594742100_R19","unstructured":"Suzuma I, Mandai M, Takagi H, Suzuma K, Otani A, Oh H, Kobayashi K, Honda Y: 17 \u03b2-estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells. Invest Ophthalmol Vis Sci\u200840:2122\u20132129,1999"},{"key":"2022031208594742100_R20","doi-asserted-by":"crossref","unstructured":"Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Honda Y: Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem\u2008274:15732\u201315739,1999","DOI":"10.1074\/jbc.274.22.15732"},{"key":"2022031208594742100_R21","doi-asserted-by":"crossref","unstructured":"Kutyavin IV, Afonina IA, Mills A, Gorn VV, Lukhtanov EA, Belousov ES, Singer MJ, Walburger DK, Lokhov SG, Gall AA, Dempcy R, Reed MW, Meyer RB, Hedgpeth J: 3\u2032-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res\u200828:655\u2013661,2000","DOI":"10.1093\/nar\/28.2.655"},{"key":"2022031208594742100_R22","doi-asserted-by":"crossref","unstructured":"Negoro S, Kunisada K, Fujio Y, Funamoto M, Darville MI, Eizirik DL, Osugi T, Izumi M, Oshima Y, Nakaoka Y, Hirota H, Kishimoto T, Yamauchi-Takihara K: Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia\/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation\u2008104:979\u2013981,2001","DOI":"10.1161\/hc3401.095947"},{"key":"2022031208594742100_R23","doi-asserted-by":"crossref","unstructured":"Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LE: Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A\u200892:10457\u201310461,1995","DOI":"10.1073\/pnas.92.23.10457"},{"key":"2022031208594742100_R24","unstructured":"Miller JW, Adamis AP, Shima DT, D\u2019Amore PA, Moulton RS, O\u2019Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B: Vascular endothelial growth factor\/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol\u2008145:574\u2013584,1994"},{"key":"2022031208594742100_R25","doi-asserted-by":"crossref","unstructured":"Stephenson K, Tunstead J, Tsai A, Gordon R, Henderson S, Dansky HM: Neointimal formation after endovascular arterial injury is markedly attenuated in db\/db mice. Arterioscler Thromb Vasc Biol\u200823:2027\u20132033,2003","DOI":"10.1161\/01.ATV.0000096394.32433.E9"},{"key":"2022031208594742100_R26","doi-asserted-by":"crossref","unstructured":"Werner N, Nickenig G: From fat fighter to risk factor: the zigzag trek of leptin. Arterioscler Thromb Vasc Biol\u200824:7\u20139,2004","DOI":"10.1161\/01.ATV.0000110908.43721.ad"},{"key":"2022031208594742100_R27","doi-asserted-by":"crossref","unstructured":"Seip M, Trygstad O: Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr Suppl\u2008413:2\u201328,1996","DOI":"10.1111\/j.1651-2227.1996.tb14262.x"},{"key":"2022031208594742100_R28","doi-asserted-by":"crossref","unstructured":"Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H: Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene\u200821:2000\u20132008,2002","DOI":"10.1038\/sj.onc.1205260"},{"key":"2022031208594742100_R29","doi-asserted-by":"crossref","unstructured":"Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y: Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A\u200898:6390\u20136395,2001","DOI":"10.1073\/pnas.101564798"},{"key":"2022031208594742100_R30","unstructured":"Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW: Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci\u200838:36\u201347,1997"},{"key":"2022031208594742100_R31","doi-asserted-by":"crossref","unstructured":"Oh H, Takagi H, Otani A, Koyama S, Kemmochi S, Uemura A, Honda Y: Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis. Proc Natl Acad Sci U S A\u200899:383\u2013388,2002","DOI":"10.1073\/pnas.012074399"},{"key":"2022031208594742100_R32","doi-asserted-by":"crossref","unstructured":"Kondo T, Vicent D, Suzuma K, Yanagisawa M, King GL, Holzenberger M, Kahn CR: Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest\u2008111:1835\u20131842,2003","DOI":"10.1172\/JCI200317455"},{"key":"2022031208594742100_R33","doi-asserted-by":"crossref","unstructured":"Fried SK, Bunkin DA, Greenberg AS: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab\u200883:847\u2013850,1998","DOI":"10.1210\/jc.83.3.847"},{"key":"2022031208594742100_R34","doi-asserted-by":"crossref","unstructured":"Abu el Asrar AM, Maimone D, Morse PH, Gregory S, Reder AT: Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am J Ophthalmol\u2008114:731\u2013736,1992","DOI":"10.1016\/S0002-9394(14)74052-8"},{"key":"2022031208594742100_R35","doi-asserted-by":"crossref","unstructured":"Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ: Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem\u2008271:736\u2013741,1996","DOI":"10.1074\/jbc.271.2.736"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/53\/9\/2443\/654246\/zdb00904002443.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/53\/9\/2443\/654246\/zdb00904002443.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:23:19Z","timestamp":1667406199000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/53\/9\/2443\/14673\/Leptin-Stimulates-Ischemia-Induced-Retinal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,1]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.53.9.2443","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,1]]}}}